Transthyretin cardiac amyloidosis (ATTR-CA) is a serious heart condition, and this study aimed to understand the relationship between various blood biomarkers and patient prognosis.
Researchers examined 2,566 patients with ATTR-CA, finding high rates of anemia, urea, hyperbilirubinemia, and elevated troponin levels, which increased with disease severity.
The study concluded that several biomarkers, especially anemia and elevated troponin levels, are independently linked to higher mortality rates in patients, with variations based on genetic factors and heart function.